Φορτώνει......
Understanding anti-leukemia responses to donor lymphocyte infusion
Donor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | , |
---|---|
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
Landes Bioscience
2014
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4203631/ https://ncbi.nlm.nih.gov/pubmed/25340010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.28187 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|